专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP3004251B1 VORRICHTUNG ZUR REGULIERUNG DES ENERGIE-DURCHTRITTS ENTHALTEND EINE DICHROITISCHE FARBSTOFFVERBINDUNG 有权
公开(公告)号：EP3004251B1
公开(公告)日：2019-03-13
申请号：EP14721765.7
申请日：2014-04-29
申请人： Merck Patent GmbH
发明人： KIRSCH, Peer , HAHN, Alexander , RUHL, Andreas , BECK, Susann , PAN, Junyou , JUNGE, Michael , BEYER, Andreas , PATWAL, Ursula
IPC分类号： C09B23/10 , C09B69/00 , C07D417/04 , C07D417/14 , C07D495/04 , C07D285/14 , H01L51/00 , C09K19/60 , C09B7/00 , C09K19/30 , C09B57/00

2. 发明公开

EP3438098A1 ANTHRACENYL ORGANIC DYE AND PREPARATION METHOD THEREFOR 审中-公开
公开(公告)号：EP3438098A1
公开(公告)日：2019-02-06
申请号：EP17773344.1
申请日：2017-05-08
申请人： Changchun Institute Of Applied Chemistry Chinese Academy Of Sciences
发明人： WANG, Peng , REN, Yameng , ZHANG, Min , WANG, Junting , LI, Yang
IPC分类号： C07D285/14 , C07D285/02 , C07D285/00 , C09B3/82 , C09B5/00 , C09B1/00 , H01G9/20
摘要： The invention provides an anthracene-based organic dye and a preparation method thereof. The organic dye provided by the invention has a structure of formula (I) or formula (II), wherein R a , R b , and R 2-1 to R 2-4 are as defined herein. The organic dye provided by the invention is obtained by modifying an anthracene with R a and R b or modifying anthracene-based groups decorated with an aryl group or a heteroaryl group with R a and R b , thereby the power conversion efficiency of a dye sensitized solar cell is significantly improved when the organic dye prepared according to the present invention is applied in a dye-sensitized solar cell. Furthermore, the preparation method of the organic dye according to the present invention is quite simple together with abundant raw materials and low cost, making it possible to be commercialized.

3. 发明公开

EP3224296A1 PREPARATION OF POLYMERS COMPRISING AT LEAST ONE BENZO[C][1,2,5]THIADIAZOL-5,6-DICARBONITRILE-UNIT 审中-公开
标题翻译：包含至少一种苯并[C] [1,2,5]噻二唑-5,6-二腈的聚合物的制备
公开(公告)号：EP3224296A1
公开(公告)日：2017-10-04
申请号：EP15798423.8
申请日：2015-11-23
申请人： BASF SE , Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V.
发明人： GESSNER, Thomas , REICHELT, Helmut , WUDARCZYK, Jakob Jacek , HINKEL, Felix Peter , MARSZALEK, Tomasz , BAUMGARTEN, Martin , MUELLEN, Klaus
IPC分类号： C08G61/12 , C07D285/14
CPC分类号： C08G61/126 , C07D285/14 , C08G61/123 , C08G2261/1412 , C08G2261/143 , C08G2261/3223 , C08G2261/3246 , C08G2261/36 , C08G2261/414 , C08G2261/51 , C08G2261/92 , H01L51/0003 , H01L51/0021 , H01L51/0036 , H01L51/0043 , H01L51/0545 , H01L51/0558 , H01L51/105
摘要： The present invention provides process for the preparation of polymers comprising at least unit of formula (1), which process comprises the step of (v) treating a compound of formula (5), wherein Y
2 is I, Br, CI or O-S(O)
2 CF
3 , with an S-donor agent, in order to obtain the compound of formula (4), wherein Y
2 is as defined for the compound of formula (5), a process for the preparation of a compound of formula (4) as well as compounds of formula (4).
摘要翻译：本发明提供了制备包含至少一个式（1）单元的聚合物的方法，该方法包括以下步骤：（v）处理式（5）的化合物，其中Y 2是I，Br，Cl或OS（O ）2CF3与一种S-供体试剂反应，以获得其中Y2如对式（5）化合物所定义的式（4）化合物，制备式（4）化合物的方法如以及式（4）的化合物。

5. 发明公开

EP3131898A1 FLUOROALKYLFLUORENE DERIVATIVES 有权
标题翻译：氟代烷基芴衍生物
公开(公告)号：EP3131898A1
公开(公告)日：2017-02-22
申请号：EP15727031.5
申请日：2015-04-17
申请人： Lomox Limited
发明人： KOCH, Gene Carl , JUDD, Luke William , ALDRED, Matthew Phillip
IPC分类号： C07D417/14 , C07C65/26 , C07C35/21 , C07C69/92 , C07C43/225 , C07D207/452 , C07D285/14 , H01L51/00
摘要： Compounds according to formula D-SÂ¹-A-BÂ¹, where: A represents -Ar1-(FL-Ar2)n-; Ar1 and Ar2 each represent a bond or an aromatic or heteroaromatic diradical, or two aromatic or heteroaromatic diradicals mutually connected by a single bond, or a FL moiety, or two FL moieties mutually connected by a single bond; n is an integer from 1-8. FL represents a 2,7- disubstituted 9,9-fluoroalkyl fluorene diradical according to the formula as shown where R preferably represents an alkyl group; S1 and S2 are flexible linker groups, preferably octyloxy groups. D represents a crosslinkable group, and may be a vinyl ether, maleimide, maleate, or fumarate group. B1 is a crosslinkable group or a hydrogen atom. The fluoroalkylfluorene derivatives may be liquid crystalline materials. Network polymers may be formed by exposure of the crosslinkable groups to radiation, preferably ultraviolet radiation. Also claimed is a device comprising a plurality of charge transport layers and/or emissive layers that contain compounds as defined above. Preferably the device is an OLED device. Preferably the OLED device comprises a light emitting layer that comprises a compound as defined above comprising a uniformly aligned liquid crystalline structure.
摘要翻译：根据式D-S-A-B-1的化合物，其中：A表示-Ar1-（FL-Ar2）n-; Ar 1和Ar 2各自表示键或芳族或杂芳族二价基团，或通过单键或FL部分或通过单键相互连接的两个FL部分相互连接的两个芳族或杂芳族二价基团; n是1-8的整数。 FL表示根据下式表示的2,7-二取代的9,9-氟烷基芴双基，其中R优选表示烷基; S1和S2是柔性连接基团，优选辛氧基。 D表示可交联基团，并且可以是乙烯基醚，马来酰亚胺，马来酸酯或富马酸酯基团。 B1是可交联基团或氢原子。氟代烷基芴衍生物可以是液晶材料。网状聚合物可通过将可交联基团暴露于辐射，优选紫外辐射而形成。还要求保护的是包含含有如上定义的化合物的多个电荷传输层和/或发射层的器件。优选地，该器件是OLED器件。优选地，OLED器件包括发光层，该发光层包含如上定义的包含均匀排列的液晶结构的化合物。

6. 发明公开

EP2964645A4 PROCESS FOR IXABEPILONE, AND INTERMEDIATES THEREOF 有权
标题翻译： VERFAHRENFÜRIXABEPILON UND ZWISCHENPRODUKTE DAVON
公开(公告)号：EP2964645A4
公开(公告)日：2016-09-07
申请号：EP14760212
申请日：2014-03-08
申请人： SCINOPHARM TAIWAN LTD
发明人： HENSCHKE JULIAN P , CHEN YUE , HSIAO TSUNG YU
IPC分类号： C07D417/06 , C07D285/14 , C07D491/044
CPC分类号： C07D491/044
摘要： The present invention relates to a novel process of making ixabepilone, ixabepilone derivatives and analogues, and intermediates thereof.
摘要翻译：本发明涉及一种制备伊沙匹隆，伊沙匹隆衍生物及其类似物的新方法及其中间体。

7. 发明公开

EP2964645A1 PROCESS FOR IXABEPILONE, AND INTERMEDIATES THEREOF 有权
标题翻译：程序对伊沙匹隆及其中间体
公开(公告)号：EP2964645A1
公开(公告)日：2016-01-13
申请号：EP14760212.2
申请日：2014-03-08
申请人： Scinopharm Taiwan Ltd.
发明人： HENSCHKE, Julian P. , CHEN, Yue , HSIAO, Tsung, Yu
IPC分类号： C07D417/06 , C07D491/044 , C07D285/14
CPC分类号： C07D491/044
摘要： The present invention relates to a novel process of making ixabepilone, ixabepilone derivatives and analogues, and intermediates thereof.

8. 发明公开

EP2804855A1 BENZOHETEROCYCLIC COMPOUNDS AND USE THEREOF 有权转让
标题翻译： BENZOHETEROCYCLISCHE VERBINDUNGEN UND VERWENDUNG DAVON
公开(公告)号：EP2804855A1
公开(公告)日：2014-11-26
申请号：EP13738359.2
申请日：2013-01-16
申请人： Tianjin Binjiang Pharma, Inc.
发明人： TIAN, Hongqi , JI, Conghui , LIU, Chunlei , KONG, Li , CHENG, Ying , HUANG, Gongchao
IPC分类号： C07D263/54 , C07D231/54 , C07D277/62 , C07D285/14 , C07D209/02 , A61K31/433 , A61K31/425 , A61K31/41 , A61K31/42 , A61P35/00 , A61P29/00
CPC分类号： A61K31/433 , A61K31/423 , A61K31/428 , C07D263/56 , C07D277/62 , C07D277/64 , C07D285/14
摘要： Disclosed are compound of formula (I) and pharmaceutically accepted salts and prodrugs thereof, wherein each of R1, R2, R3, R4, R5, R6, X1 and X2 is as defined in the description. These compounds are protein kinases inhibitors, especially the inhibitors of Mek, which are useful in the treatment of cancers and inflammation of mammals. Disclosed are the treatment methods of cancers and inflammation of mammals as well as pharmaceutical compositions comprising the compounds described herein. The preparation of benzoheterocyclic compounds are disclosed. Disclosed are the preparation of potential drug candidates, such as benzooxazol, benzothiazol, benzothiadiazol and the like.
摘要翻译：公开了式（I）化合物及其药学上可接受的盐和前药，其中R1，R2，R3，R4，R5，R6，X1和X2各自如说明书中所定义。这些化合物是蛋白激酶抑制剂，特别是Mek的抑制剂，其可用于治疗哺乳动物的癌症和炎症。公开了哺乳动物的癌症和炎症的治疗方法以及包含本文所述的化合物的药物组合物。公开了苯并杂环化合物的制备。公开了潜在的候选药物的制备，例如苯并恶唑，苯并噻唑，苯并噻二唑等。

9. 发明公开

EP2609089A1 SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS 审中-公开
标题翻译：选择性的17-β-羟基类固醇脱氢酶类型1抑制剂
公开(公告)号：EP2609089A1
公开(公告)日：2013-07-03
申请号：EP11748434.5
申请日：2011-08-29
申请人： Universität des Saarlandes , Elexopharm GmbH
发明人： HARTMANN, Rolf , FROTSCHER, Martin , MARCHAIS-OBERWINKLER, Sandrine , OSTER, Alexander , SPADARO, Alessandro
IPC分类号： C07D277/24 , C07D285/14 , C07D333/22 , C07D409/04 , A61K31/381 , A61K31/426 , A61K31/428 , A61P5/24
CPC分类号： C07D277/24 , C07D285/14 , C07D333/22 , C07D409/04
摘要： The invention relates to selective, non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors their production and use, especially for the treatment and/or prophylaxis of hormone-related diseases.

10. 发明公开

EP2411365A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS 有权
标题翻译： 2,3-二芳基或杂芳基取代的1,1,1-三氟-2-羟基丙基化合物
公开(公告)号：EP2411365A1
公开(公告)日：2012-02-01
申请号：EP10709740.4
申请日：2010-03-23
申请人： F.Hoffmann-La Roche AG
发明人： HUNZIKER, Daniel , LERNER, Christian , MUELLER, Werner , OBST SANDER, Ulrike , PFLIEGER, Philippe , WALDMEIER, Pius
IPC分类号： C07D213/63 , C07D235/26 , C07D263/58 , C07D265/36 , C07D285/14 , C07D317/46 , C07D317/54 , C07D401/12 , C07D413/12 , C07D455/02 , C07D498/04 , A61K31/536 , A61K31/5415 , C07C255/53 , A61P3/10
CPC分类号： C07D413/10 , C07C255/54 , C07C255/57 , C07D213/63 , C07D235/26 , C07D263/58 , C07D265/36 , C07D285/14 , C07D317/46 , C07D317/54 , C07D317/60 , C07D401/10 , C07D401/12 , C07D403/12 , C07D413/12 , C07D455/02 , C07D498/04
摘要： The present invention relates to compounds of formula (I), wherein R
1a to R
1e , R
2 , R
3 and R
5 are as defined in the description and claims and R
4 signifies a bicyclic heteroaryl group or a cyanophenyl group, as well as pharmaceutically 5 acceptable salts thereof. The compounds are glucocorticoid receptor antagonists useful for the treatment and/or prevention of diseases such as diabetes, dyslipidemia, obesity, hypertension, cardiovascular diseases, adrenal imbalance or depression.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式